Latest
Drug Science is the leading independent scientific body on drugs in the UK. We work to provide clear, evidence-based information without political or commercial interference.
What is ayahuasca? Ayahuasca is a psychedelic brew originating from the Amazon, originally used by indigenous populations and later involved for local syncretic purposes. Since it’s origins, ayahuasca has spread across the world and has developed a more varied list of uses. The two hallmark ingredients of ayahuasca are: 1) the…
- December 13, 2021
Increasing Diversity in Psychedelic Science Research In order to generate research that is relevant to the masses, it is imperative that the field of psychedelic science involves a level of diversity that is representative of those it intends to treat. This renaissance of psychedelic research thus far has not sufficiently involved…
- December 7, 2021
The British Paediatric Neurology Association (BPNA) recently produced new guidance on the prescription of cannabis medicines for children with epilepsy. However, the Medical Cannabis Clinicians Society (UKMCCS) and Drug Science fundamentally disagree with this guidance. Expert clinicians from both organisations have produced a critique to provide commentary, evidence and further crucial information…
- December 6, 2021
This webinar was recorded during a Drug Science Live Event which included a live Q&A session from the audience. If you want to ensure that you don’t miss any of our events, so that you can ask your questions live, all you need to do is join the Drug Science Mailing…
- December 1, 2021
The 24th of November 2021 was a remarkable day for German drug policy reformers and cannabis enthusiasts. The federal election allowed a coalition to form, which is called the “traffic light coalition” due to the individual parties’ colours. Whilst two parties, the Greens and the FDP, are campaigning for cannabis legalisation…
- November 29, 2021
A fascinating Q&A on the ethical and philosophical considerations in psychedelic science and explanations of the psychedelic experience. Prof David Nutt David is a leading Neuroscientist and drug policy reform advocate. Formerly the Chief Drug Advisor to the UK government he is currently the Edmond J. Safra Professor of Neuropsychopharmacology…
- November 20, 2021